ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2016

Jan 5, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2016-01-01

Reporting Person: O'Brien Patrick (General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-01	Stock Options	$6.15	A	60000	Acquired	2026-01-01	Common Stock (60000)	Direct

Footnotes

F1: Option vests and becomes exercisable over a four year period from date of grant.